| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/15/2009 | WO2009006732A1 Bifunctional fusion proteins of the alpha-melanocyte stimulating hormone (alpha-msh) and atrial natriuretic protein (anp) and uses in hypertension and acute kidney injury |
| 01/15/2009 | WO2009006700A1 Immunology treatment for biofilms |
| 01/15/2009 | WO2009006680A1 Epitopes of herpes simplex virus |
| 01/15/2009 | WO2008140637A9 Secreted staphylococcus aureus proteins and peptides for use in inhibiting activation of the complement system |
| 01/15/2009 | WO2008128730A3 Antagonists of bitter taste receptors and uses thereof |
| 01/15/2009 | WO2008116913A3 Peptide compounds with transient biodegradable pegylation |
| 01/15/2009 | WO2008113013A3 C-met mutations and uses thereof |
| 01/15/2009 | WO2008108660A3 Fish disease detection |
| 01/15/2009 | WO2008105890A3 Chloroplast transit peptides for efficient targeting of dmo and uses thereof |
| 01/15/2009 | WO2008104803A3 Proteins |
| 01/15/2009 | WO2008099189A3 Herpes simplex viruses and methods of viral replication |
| 01/15/2009 | WO2008097854A4 Method and substances for treating hpv infection |
| 01/15/2009 | WO2008088582A9 Methods and materials related to trail isoforms |
| 01/15/2009 | WO2008057683A3 Methods for the purification of polypeptide conjugates |
| 01/15/2009 | WO2008047150A3 Protein variants |
| 01/15/2009 | WO2008021408A3 Methods and compositions for treatment and diagnosis of autoimmune encephalitis or epilepsy |
| 01/15/2009 | WO2008017598A3 Citrusal aroma receptors and use of myrac aldehyde derivatives for increasing the flagellation frequency of a spermatozoon |
| 01/15/2009 | WO2007101602A9 Chimeric kunitz domains and their use |
| 01/15/2009 | US20090019609 Expression of Cry3B Insecticidal Protein in Plants |
| 01/15/2009 | US20090019602 Master activators of pathogen responsive genes |
| 01/15/2009 | US20090019601 Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
| 01/15/2009 | US20090019598 Anther specific promoters and uses thereof |
| 01/15/2009 | US20090019555 increased lung mucus retention and its genome comprises a promoter linked to a heterologous DNA encoding an epithelial sodium channel subunit; useful in treatment of bronchitis and asthma; drug screening |
| 01/15/2009 | US20090018319 DNA sequence in plant Caragana jubata with freeze tolerance |
| 01/15/2009 | US20090018316 Propagating interleukin-15 specific monoclonal antibody for use as tool in controllig immune response |
| 01/15/2009 | US20090018315 B7-H3 and B7-H4, Novel Immunoregulatory Molecules |
| 01/15/2009 | US20090018313 Using trisodium citrate wash as tool in recovering fibrinogin from cryo-solution; preparing fibrin fabric for use in surgery and as wound healing agent |
| 01/15/2009 | US20090018312 Igf-1 receptor interacting proteins |
| 01/15/2009 | US20090018310 Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
| 01/15/2009 | US20090018144 Capped pyrazinoylguanidine sodium channel blockers |
| 01/15/2009 | US20090018095 Antigen, nucleic acid encodes fusion protein; polynucleotides; nucleoside sequences |
| 01/15/2009 | US20090018083 Methods and compositions for inhibition of bcl6 repression |
| 01/15/2009 | US20090018081 Activatable clostridial toxins |
| 01/15/2009 | US20090018080 Methods for treating viral infection using il-28 and il-29 cysteine mutants |
| 01/15/2009 | US20090018079 Optimized dna and protein sequence of an antibody to improve quality and yield of bacterially expressed antibody fusion proteins |
| 01/15/2009 | US20090018077 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018076 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018075 Peptides in Inhibiting Insects |
| 01/15/2009 | US20090018074 Peptides for Inhibiting Insects |
| 01/15/2009 | US20090018073 Administering polypeptide of growth factor to increase mitogenesis; bind to receptors and increase cell differentiation and survival |
| 01/15/2009 | US20090018071 Epididymis-specific receptor protein |
| 01/15/2009 | US20090018070 Fsh Mutants |
| 01/15/2009 | US20090018069 Methods and Compositions Related to Mutant Kunitz Domain I of Tfpi-2 |
| 01/15/2009 | US20090018068 G-protein coupled receptors |
| 01/15/2009 | US20090018067 Regulatory t cell epitopes, compositions and uses thereof |
| 01/15/2009 | US20090018066 Pharmaceutical compositions for modulating the activity of a novel triglyceride hydrolase |
| 01/15/2009 | US20090018063 Compositions and methods for the treatment of disorders involving epithelial cell apoptosis |
| 01/15/2009 | US20090018060 Thymus-specific protein |
| 01/15/2009 | US20090018030 Polymorphisms in the human genes for OCT1 and their use in diagnostic and therapeutic applications |
| 01/15/2009 | US20090018016 Bacterial glutamine synthetases and methods of use |
| 01/15/2009 | US20090017558 Apolipoprotein e stable folding intermediate and methods of use thereof |
| 01/15/2009 | US20090017542 producing high titer, wild-type-free preparations of recombinant AAV (adeno-associated virus) virions; for use as tools in genetic engineering and gene therapy |
| 01/15/2009 | US20090017537 hT2R54 Receptor Polypeptides and Nucleic Acid Sequences |
| 01/15/2009 | US20090017535 Biomarkers; fusion proteins |
| 01/15/2009 | US20090017534 Nucleotide sequences coding voltage-gated transport proteins for use as screening tools to identify modulators for treatment and prevention of nervous, muscular, glandular, immune, reproductive and epithelial tissue disorders |
| 01/15/2009 | US20090017532 Vector |
| 01/15/2009 | US20090017522 proteolytic fragment of a growth differentiation factor (GDF) polypeptide (pro-GDF) or a functional peptide portion thereof; affects activity associated with GDF signal transduction |
| 01/15/2009 | US20090017521 Chimaeric phages |
| 01/15/2009 | US20090017516 Target physiological function inactivator using photosensitizer-labeled fluorescent protein |
| 01/15/2009 | US20090017502 Interferon-alpha polypeptides and conjugates |
| 01/15/2009 | US20090017501 Interferon-alpha polypeptides and conjugates |
| 01/15/2009 | US20090017500 Covalently attached to a nonpeptide moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells; administering antiviral polypeptide |
| 01/15/2009 | US20090017499 Rank ligand-binding polypeptides |
| 01/15/2009 | US20090017497 Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast |
| 01/15/2009 | US20090017496 Co-expression of multiple protein chains or subunits |
| 01/15/2009 | US20090017495 Escherichia coli-derived vaccine and therapy against botulism |
| 01/15/2009 | US20090017494 Tick octopamine receptor nucleic acid molecules, proteins and uses thereof |
| 01/15/2009 | US20090017479 Ly6h gene |
| 01/15/2009 | US20090017473 Compositions and methods for the diagnosis and treatment of tumor |
| 01/15/2009 | US20090017471 SOLUBLE ErbB3 METHOD OF DETECTION |
| 01/15/2009 | US20090017468 Method of screening compound directly activating glycogen synthase |
| 01/15/2009 | US20090017161 Gene encoding protein having trehalose synthesis-promoting activity and use thereof |
| 01/15/2009 | US20090017077 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 01/15/2009 | US20090017073 Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof |
| 01/15/2009 | US20090017066 Novel vlps derived from cells that do not express a viral matrix or core protein |
| 01/15/2009 | US20090017061 Mycobacteria with Mannose Cap-Deficient Lipoarabinomannan |
| 01/15/2009 | US20090017055 immunogenic composition comprising an isolated polypeptide effective for inducing an immune response to liver stage Plasmodium falciparum in a mammalian subject, and a pharmaceutically acceptable carrier; use in the prevention, diagnosis, and treatment of malaria |
| 01/15/2009 | US20090017054 nucleic acids corresponding to entire coding sequences of S. pneumoniae proteins, including surface or secreted proteins or parts thereof; for diagnostics, prophylaxis and treatment of bacterial infection; vaccines |
| 01/15/2009 | US20090017051 Allergy vaccines and their preparation |
| 01/15/2009 | US20090017050 Egfr antigen-binding molecules and uses thereof |
| 01/15/2009 | US20090017048 Novel Brachyspira hyodysenteriae vaccine |
| 01/15/2009 | US20090017045 relate to various cell proliferative disorders, especially those involving muscle, nerve, and adipose tissue |
| 01/15/2009 | US20090017034 inhibits thymic stromal lymphopoietin TSLP)-mediated lymphocyte stimulation; using these polypeptides as molecular weight markers that allow the estimation of the molecular weight of a protein or a fragmented protein |
| 01/15/2009 | US20090017033 Inhibiting receptor activated nuclear factor kappa beta ligand (RANKL); immunoregulation |
| 01/15/2009 | US20090017032 Mammalian cx3c chemokine antibodies |
| 01/15/2009 | US20090017030 Endothelial Cell Expression Patterns |
| 01/15/2009 | US20090017018 Uses of mammalian cytokine: related reagents |
| 01/15/2009 | US20090017014 Compositions and methods for the treatment of immune related diseases |
| 01/15/2009 | US20090017009 Method for the diagnosis and prognosis of malignant diseases |
| 01/15/2009 | US20090016988 Modified Pore-Forming Protein Toxins and Use Thereof |
| 01/15/2009 | US20090016987 Pharmaceutical composition and therapeutic method |
| 01/15/2009 | US20090016959 Drug delivery across the blood-brain barrier using polypeptides; neurological diseases; aprotinin |
| 01/15/2009 | US20090016957 Polypeptides |
| 01/15/2009 | US20090014562 Spray Nozzle Apparatus and Method of Use |
| 01/15/2009 | DE4407386B4 Verfahren zur Reaktivierung von gereinigten Membranproteinen durch Einfrieren A process for reactivating purified membrane proteins by freezing |
| 01/15/2009 | DE10222714B4 Kofaktoren, die spezifisch mit dem Glukokortikoidrezeptor interagieren sowie Verfahren zu deren Identifizierung Cofactors, specifically interact with the glucocorticoid receptor and methods for their identification |
| 01/15/2009 | CA2693717A1 Immunology treatment for biofilms |
| 01/15/2009 | CA2693651A1 Bioactive peptides and method of using same |
| 01/15/2009 | CA2693392A1 Novel compounds and their effects on feeding behaviour |
| 01/15/2009 | CA2692814A1 Purification of factor viii using a mixed-mode or multimodal resin |